Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
4.83T | 3.83T | 3.12T | 2.88T | 3.43T | Gross Profit |
1.04T | 801.52B | 687.70B | 613.64B | 746.64B | EBIT |
250.50B | 141.97B | 101.84B | 8.82B | 43.60B | EBITDA |
419.51B | 247.92B | 192.12B | 98.58B | 135.87B | Net Income Common Stockholders |
207.70B | 142.81B | 81.56B | -31.65B | 12.13B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
922.56B | 717.10B | 740.39B | 739.00B | 568.96B | Total Assets |
3.79T | 3.26T | 2.97T | 2.92T | 2.79T | Total Debt |
575.79B | 627.13B | 680.81B | 755.93B | 619.87B | Net Debt |
-242.77B | -89.97B | -59.58B | 17.14B | 51.87B | Total Liabilities |
2.03T | 1.80T | 1.65T | 1.72T | 1.58T | Stockholders Equity |
1.74T | 1.44T | 1.30T | 1.18T | 1.18T |
Cash Flow | Free Cash Flow | |||
303.65B | 38.30B | 49.80B | 34.02B | -87.52B | Operating Cash Flow |
418.89B | 137.42B | 189.16B | 120.06B | 34.83B | Investing Cash Flow |
-179.89B | -99.43B | -136.24B | -78.86B | -127.58B | Financing Cash Flow |
-84.70B | -89.86B | -86.41B | 99.35B | -24.27B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $42.23B | 8.51 | 11.47% | 5.65% | 3.03% | 28.54% | |
75 Outperform | $230.95B | 7.58 | 13.36% | 3.47% | -0.59% | 7.56% | |
75 Outperform | $3.70B | 4.97 | 6.30% | 3.82% | -2.11% | -39.87% | |
74 Outperform | $47.74B | 8.50 | 6.54% | 3.64% | 4.37% | 6.93% | |
73 Outperform | $47.37B | 7.10 | 8.88% | 1.22% | 7.76% | -14.17% | |
62 Neutral | $6.88B | 11.07 | 2.77% | 4.28% | 2.67% | -24.94% | |
41 Neutral | $7.26B | ― | -240.42% | ― | 23.39% | 3.93% |